CRBP Corbus Pharmaceuticals Holdings Forecast, Technical & Fundamental Analysis
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways... Show more
CRBP is expected to report earnings to rise 2.44% to -125 cents per share on August 11
Q2'26
Est.
$-1.26
Q1'26
Beat
by $0.15
Q4'25
Beat
by $0.14
Q3'25
Missed
by $0.62
Q2'25
Missed
by $0.21
The last earnings report on May 12 showed earnings per share of -123 cents, beating the estimate of -137 cents. With 327.32K shares outstanding, the current market capitalization sits at 140.07M.
A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with XNCR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then XNCR could also see price increases.
CRBP saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on May 18, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CRBP moved out of overbought territory on May 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRBP as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
CRBP moved below its 50-day moving average on May 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRBP crossed bearishly below the 50-day moving average on May 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRBP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CRBP advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .
CRBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.109) is normal, around the industry mean (19.817). P/E Ratio (0.000) is within average values for comparable stocks, (36.300). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.691). CRBP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (0.000) is also within normal values, averaging (355.038).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CRBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
